Study to Assess the Effects of Allergic Rhinitis and Co-administration of Mometasone or Oxymetazoline on the Pharmacokinetics, Safety, and Tolerability of Intranasal Esketamine
Clinical trial NCT02154334 · COMPLETED
Trial details
- NCT number
- NCT02154334
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2014-10-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.